1. Home
  2. IMNM vs ESQ Comparison

IMNM vs ESQ Comparison

Compare IMNM & ESQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMNM
  • ESQ
  • Stock Information
  • Founded
  • IMNM 2006
  • ESQ 2006
  • Country
  • IMNM United States
  • ESQ United States
  • Employees
  • IMNM N/A
  • ESQ N/A
  • Industry
  • IMNM Medicinal Chemicals and Botanical Products
  • ESQ Commercial Banks
  • Sector
  • IMNM Health Care
  • ESQ Finance
  • Exchange
  • IMNM Nasdaq
  • ESQ Nasdaq
  • Market Cap
  • IMNM 585.5M
  • ESQ 638.2M
  • IPO Year
  • IMNM 2020
  • ESQ 2017
  • Fundamental
  • Price
  • IMNM $11.08
  • ESQ $85.68
  • Analyst Decision
  • IMNM Strong Buy
  • ESQ Hold
  • Analyst Count
  • IMNM 5
  • ESQ 3
  • Target Price
  • IMNM $28.60
  • ESQ $88.00
  • AVG Volume (30 Days)
  • IMNM 1.0M
  • ESQ 113.9K
  • Earning Date
  • IMNM 03-27-2025
  • ESQ 01-23-2025
  • Dividend Yield
  • IMNM N/A
  • ESQ 0.81%
  • EPS Growth
  • IMNM N/A
  • ESQ 4.68
  • EPS
  • IMNM N/A
  • ESQ 5.14
  • Revenue
  • IMNM $10,129,000.00
  • ESQ $120,124,000.00
  • Revenue This Year
  • IMNM N/A
  • ESQ N/A
  • Revenue Next Year
  • IMNM N/A
  • ESQ $10.75
  • P/E Ratio
  • IMNM N/A
  • ESQ $16.70
  • Revenue Growth
  • IMNM N/A
  • ESQ 10.21
  • 52 Week Low
  • IMNM $8.97
  • ESQ $44.45
  • 52 Week High
  • IMNM $30.96
  • ESQ $90.18
  • Technical
  • Relative Strength Index (RSI)
  • IMNM 54.91
  • ESQ 55.86
  • Support Level
  • IMNM $10.29
  • ESQ $81.10
  • Resistance Level
  • IMNM $11.43
  • ESQ $90.18
  • Average True Range (ATR)
  • IMNM 0.77
  • ESQ 2.94
  • MACD
  • IMNM 0.18
  • ESQ 0.09
  • Stochastic Oscillator
  • IMNM 85.23
  • ESQ 60.95

About IMNM Immunome Inc.

Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which itcan efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious disease, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP) and and IM-4320.

About ESQ Esquire Financial Holdings Inc.

Esquire Financial Holdings Inc is a full-service commercial bank dedicated to serving the financial needs of the legal industry and small businesses nationally, as well as commercial and retail customers in the New York metropolitan area. The Bank offers tailored products and solutions to the legal community and their clients as well as dynamic and flexible payment processing solutions to small business owners. Banking products offered for businesses and consumers include checking, savings, money market, and time deposits; a wide range of commercial and consumer loans, as well as customary banking services. The Bank operates a payment processing platform through third-party Independent Sales Organizations.

Share on Social Networks: